ASX:CURE

Global X S&P Biotech ETF (CURE) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2,243 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CURE stock logo

About Global X S&P Biotech ETF Stock (ASX:CURE)

CURE Stock News Headlines

War Over Taiwan? Protect Your Wealth NOW
With tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared.
War Over Taiwan? Protect Your Wealth NOW
With tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared.
Defence's AccuTOX(R) Impairs Lung Cancer Growth
Biotechtech Stocks Find a Cure: M&A
These 3 Biotech Stocks Have Strong Upside Potential, Says Deutsche Bank
Here's what to expect from Burning Rock Biotech's earnings report
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
5 Best Pharma ETFs
See More Headlines
Receive CURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (ASX:CURE) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners